Functional deficiency in endogenous interleukin-1 receptor antagonist in patients with febrile infection-related epilepsy syndrome

New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives

(2018) Nicolas Gaspard et al.   EPILEPSIA

Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions

(2018) Lawrence J. Hirsch et al.   EPILEPSIA

Systemic autoinflammation with intractable epilepsy managed with interleukin-1 blockade

(2018) Allen D. DeSena et al.   Journal of Neuroinflammation

Tocilizumab treatment for new onset refractory status epilepticus

(2018) Jin-Sun Jun et al.   ANNALS OF NEUROLOGY

Early ictal and interictal patterns in FIRES: The sparks before the blaze

(2017) Raquel Farias-Moeller et al.   EPILEPSIA

Interleukin-1 Receptor in Seizure Susceptibility after Traumatic Injury to the Pediatric Brain

(2017) Bridgette D. Semple et al.   JOURNAL OF NEUROSCIENCE

Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy

(2017) Valentina Iori et al.   NEUROBIOLOGY OF DISEASE

Clinical profile and treatment outcome of febrile infection-related epilepsy syndrome in South Indian children

(2016) KollencheriPuthenveettil Vinayan et al.   Annals of Indian Academy of Neurology

Febrile infection-related epilepsy syndrome treated with anakinra

(2016) Daniel L. Kenney-Jung et al.   ANNALS OF NEUROLOGY

Cytokine-related and sodium channel polymorphism as candidate predisposing factors for childhood encephalopathy FIRES/AERRPS

(2016) M. Saitoh et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

IL-1ra Secreted by ATP-Induced P2Y2Negatively Regulates MUC5AC Overproduction via PLCβ3 during Airway Inflammation

(2016) Jee-Yeong Jeong et al.   MEDIATORS OF INFLAMMATION

A Practical Approach to Ketogenic Diet in the Pediatric Intensive Care Unit for Super-Refractory Status Epilepticus

(2016) Raquel Farias-Moeller et al.   Neurocritical Care

Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus

(2014) Hiroshi Sakuma et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Pharmacological blockade of IL-1β/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy

(2013) F.M. Noe et al.   NEUROBIOLOGY OF DISEASE

Design of a superior cytokine antagonist for topical ophthalmic use

(2013) J. Hou et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Febrile infection-related epilepsy syndrome: A study of 12 patients

(2013) Roberto H. Caraballo et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

A novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset

(2012) Ender Altiok et al.   CLINICAL IMMUNOLOGY

Febrile infection-related epilepsy syndrome (FIRES) is not caused bySCN1A, POLG, PCDH19mutations or rare copy number variations

(2012) SILKE APPENZELLER et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Microglial microvesicle secretion and intercellular signaling

(2012) Elena Turola   Frontiers in Physiology

IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures

(2011) Annamaria Vezzani et al.   BRAIN BEHAVIOR AND IMMUNITY

Understanding the mechanism of IL-1β secretion

(2011) Gloria Lopez-Castejon et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Long-term follow-up of febrile infection-related epilepsy syndrome

(2011) Katherine B. Howell et al.   EPILEPSIA

Febrile infection-related epilepsy syndrome (FIRES): Pathogenesis, treatment, and outcome

(2011) Uri Kramer et al.   EPILEPSIA

Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA

(2010) Stéphane Auvin et al.   EPILEPSIA

Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes

(2010) K. Luotola et al.   JOURNAL OF INTERNAL MEDICINE

Acute encephalopathy with inflammation-mediated status epilepticus

(2010) Rima Nabbout et al.   LANCET NEUROLOGY

Genetic variation of the interleukin-1 family and nongenetic factors determining the interleukin-1 receptor antagonist phenotypes

(2010) Kari Luotola et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Mechanisms of interleukin-1β release

(2009) Claudia Eder   IMMUNOBIOLOGY

Functional characterization of mouse spinal cord infiltrating CD8+ lymphocytes

(2009) Chandra Deb et al.   JOURNAL OF NEUROIMMUNOLOGY

Levels of IL-1β and IL-1ra in Cerebrospinal Fluid of Human Patients after Single and Prolonged Seizures

(2009) Kai A. Lehtimäki et al.   NEUROIMMUNOMODULATION

An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist

(2009) Ivona Aksentijevich et al.   NEW ENGLAND JOURNAL OF MEDICINE

An Autoinflammatory Disease Due to Homozygous Deletion of theIL1RNLocus

(2009) Sreelatha Reddy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Human Splicing Finder: an online bioinformatics tool to predict splicing signals

(2009) François-Olivier Desmet et al.   NUCLEIC ACIDS RESEARCH

Antagonism of peripheral inflammation reduces the severity of status epilepticus

(2008) Nicola Marchi et al.   NEUROBIOLOGY OF DISEASE